secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvation Bio Inc. (NUVB)
CIK:        0001811063
Form:       8-K
Filed at:   2025-03-25T23:59:59+00:00
Accession:  0001193125-25-062031
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuvation Bio enters commercial supply agreement with Asymchem for taletrectinib drug product
--------------------------------------------------------------------------------

- Asymchem will be non-exclusive supplier of taletrectinib drug product; Nuvation retains right to use alternate manufacturers.
- Orders must be placed at least 180 days before delivery; cancellation subject to tiered fees.
- Initial term is 5 years, auto-renews for consecutive 3-year terms unless non-renewed.
- Company may terminate without cause on 30 days' notice; each party may terminate for material breach or insolvency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811063/000119312525062031/0001193125-25-062031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811063/000119312525062031/d908716d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-062031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer